Safety and activity of the TGFβ receptor I kinase inhibitor galunisertib plus the anti-PD-L1 antibody durvalumab in metastatic pancreatic cancer
=================================================================================================================================================

* Davide Melisi
* Do-Youn Oh
* Antoine Hollebecque
* Emiliano Calvo
* Anna Varghese
* Erkut Borazanci
* Teresa Macarulla
* Valeria Merz
* Camilla Zecchetto
* Yumin Zhao
* Ivelina Gueorguieva
* Michael Man
* Leena Gandhi
* Shawn T Estrem
* Karim A Benhadji
* Mark C Lanasa
* Emin Avsar
* Susan C Guba
* Rocio Garcia-Carbonero